NCT03760003 2025-11-28
Dose-Ranging Phase 2b Study of ABX464 in Moderate to Severe Ulcerative Colitis
Abivax S.A.
Phase 2 Completed
Clinical Trials
15 trialsNCT05796245 2025-06-04
A Study to Learn About the Study Medicine Called Infliximab (Genetical Recombination)[Infliximab Biosimilar 3] in People With Rheumatoid Arthritis, Ulcerative Colitis, Crohn's Disease, or Psoriasis
Pfizer
Completed
NCT01804166 2025-02-04
A Research Study to Bank Samples for Future Evaluation to Identify Biomarkers That Predispose Crohn's Disease and Ulcerative Colitis Patients to Develop Hepatosplenic T-Cell Lymphoma (HSTCL)
Janssen Scientific Affairs, LLC
Phase 4 Completed
NCT05156125 2024-11-13
VTX002 Versus Placebo for the Treatment of Moderately to Severely Active Ulcerative Colitis
Oppilan Pharma Ltd
Phase 2 Active not recruiting
NCT03710486 2024-05-30
EVOLVE-IBERIA
Takeda
Completed
NCT02136069 2021-12-03
GARDENIA
Hoffmann-La Roche
Phase 3 Completed
NCT02165215 2021-08-19
LAUREL
Hoffmann-La Roche
Phase 3 Completed
NCT02100696 2021-08-13
HICKORY
Hoffmann-La Roche
Phase 3 Completed
NCT02163759 2021-07-23
HIBISCUS I
Hoffmann-La Roche
Phase 3 Completed
NCT02171429 2021-07-23
HIBISCUS II
Hoffmann-La Roche
Phase 3 Completed
NCT02093663 2021-06-09
PACE
Takeda
Phase 3 Completed
NCT01805791 2020-01-02
A Phase III Trial of HMPL-004 in Patients With Mild to Moderate Active Ulcerative Colitis
Hutchmed
Phase 3 Terminated
NCT00663819 2018-04-17
Bioabsorbable Staple Line Reinforcement in Colorectal,Coloanal and Ileoanal Anastomoses
W.L.Gore & Associates
Phase NA Terminated
NCT02092389 2017-02-23
AdaProQuo
AbbVie
Terminated
NCT01002287 2014-11-20
An Evaluation of SprayShield in Reducing Post-Operative Adhesion Formation Following Major Open Abdominal Surgery
Integra LifeSciences Corporation
Phase NA Terminated